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a b s t r a c t
Over an approximately 50-day period in 2015, an outbreak of CTX-M-15 extended spectrum β-lactamase(ESBL)-possessing Salmonella Isangi occurred among 19 adult surgical patients and one healthcare worker
(HCW) at a large urban tertiary care hospital in the United States. A total of 45 S. Isangi isolates were isolated
from stool (35), blood (4), urine (3), respiratory (2), and wound (1) cultures. Phenotypically, all but three isolates
demonstrated resistance to ampicillin, ampicillin/sulbactam, ceftriaxone, and cefepime, and one isolate was resistant to ertapenem. Genotypically, a single CTX-M-15 ESBL was identiﬁed in all but three isolates by realtime PCR. Interestingly, two of the CTX-M-15 negative, susceptible isolates were isolated from a single patient
who initially had a CTX-M positive, resistant strain. Isolates were clonally related, including both resistant and
susceptible strains, as conﬁrmed by pulse ﬁeld gel electrophoresis (PFGE). This is the ﬁrst case of a novel Salmonella outbreak at this hospital, and we believe it to be the ﬁrst case of an S. Isangi serotype outbreak in the United
States.
© 2016 Elsevier Inc. All rights reserved.

1. Introduction
Salmonella spp. effectively colonize a range of host species and can
potentially cause a wide spectrum of disease in humans and animals,
including mammals, reptiles and birds (Pegues, 2015). Nontyphoidal
Salmonella (NTS) infections are a major cause of foodborne gastroenteritis worldwide. Invasive NTS disease, including septicemia,
endovascular infection, and meningitis, can cause signiﬁcant morbidity
and mortality in infants, young children, and among immunocompromised individuals, particularly in sub-Saharan Africa (Feasey et al.,
2012; Usha et al., 2008; Wadula et al., 2006).
While most Salmonella infections are self-limiting, invasive salmonellosis requires antimicrobial treatment (Feasey et al., 2012; Usha et al.,
2008; Wadula et al., 2006). However, resistance against commonly
used antimicrobials, including ampicillin, chloramphenicol, and sulfamethoxazole, has necessitated the use of ﬂoroquinolones and
extended-spectrum cephalosporins (ceftriaxone and cefotaxime), particularly in children (Feasey et al., 2012; Usha et al., 2008; Krauland et al.,
⁎ Corresponding author. Tel.: +1-313-916-9381; fax: +1-313-916-8309.
E-mail address: rtibbet1@hfhs.org (R.J. Tibbetts).

2009; Kruger et al., 2004). Consequently, this has promoted the development of extended-spectrum β-lactamase-(ESBL)-production in Salmonella. Although ESBL-production is predominantly associated with
E. coli, Klebsiella spp, Proteus spp. and other species in the Enterobacteriaceae family, the emergence of ESBL in Salmonella has become increasing
more prevalent in recent years (Usha et al., 2008; Kruger et al., 2004).
ESBLs in Salmonella were ﬁrst reported in Africa in the late 1980s
(Hammami et al., 1991) and have since become more widespread due
to transmissible mobile genetic elements that produce a variety of
ESBL enzymes, including TEM, SHV, and CTX-M. Moreover, ESBLproducing Salmonella Isangi and Typhimurium have become common
in South Africa, and S. Isangi has acquired various CTX-M enzymes, including CTX-M-15 and CTX-M-37 (Usha et al., 2008; Wadula et al.,
2006; Kruger et al., 2004). During the last decade, CTX-M enzymes, particularly CTX-M15, have become the dominant ESBL type due to their
mobilizing ability by insertion sequences and integrons (Dropa et al.,
2015; Woerther et al., 2013).
Over an approximately 50-day period in 2015, an outbreak of a novel
ESBL-producing S. Isangi was identiﬁed among 19 surgical patients and
one healthcare worker (HCW) at an 800-bed tertiary-care teaching
hospital in southeast Michigan. In this study, we report the
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positive. Further conﬁrmation was determined by sequence analysis of
ampliﬁed products at the DNA Sequencing Lab,Applied Genomics Technology Center, Wayne State University, Detroit MI.

2. Materials and Methods
2.3. Pulse Field Gel Electrophoresis
2.1. Isolates
Pea-sized portions of fresh stool, 1 ml of unformed stool, stool in
Cary-Blair transport media (ThermoFisher, Middletown, VA), or rectal
swabs from patients and HCWs were used to inoculate 5 ml of
tetrathionate (TT) enrichment broth (Remel, Lenexa, KS) followed by
the addition of 200 ul of tetrathionate iodine solution and overnight incubation of tubes at 37° C. After the overnight incubation, 100 ul of the
enrichment broth was used to inoculate Hektoen-Enteric (HE) agar
plates (Remel, Lenexa, KS), which were incubated at 37°C overnight.
Hydrogen sulﬁde-producing colonies on HE plates were identiﬁed by either the Vitek MS or the Vitek-2 automated identiﬁcation and antimicrobial susceptibility testing platform (bioMerieux, Durham, NC)
according to manufacturers procedures. Antimicrobial susceptibility
patterns were also determined using the Vitek-2 according to
manufacturer's procedures. Non-stool specimens were isolated via routine culture, and identiﬁcation and susceptibility testing were performed as above. These organisms were suspended and frozen at -20
°C in trypticase soy broth with 20% glycerol (Fisher Scientiﬁc).
Serotyping of the Salmonella isolates was performed by the Michigan
Department of Health and Human Services (MDHHS) using classic
antisera to the O and H antigens as described previously (Brenner and
McWhorter-Murlin, 1998).
2.2. DNA extraction/PCR
Salmonella isolates were subcultured onto blood agar, and total and
plasmid DNA was extracted using the Qiagen® DNeasy® Blood and Tissue and the QIAPrep plasmid kits (Qiagen, Valencia, CA), respectively,
according to manufacturer's instructions. For PCR, universal primers
for CTX–M ESBLs (CTX-Mu-F 5’-CGCTTTGCGATGTGCAG-3’and CTXMu-R 5’- ACCGCGATATCGTTGGT-3’) were used (Grobner et al., 2009).
Each well in a 96-well plate received 5 μl of iQ SYBR® Green Supermix
reaction buffer (BioRad, Berkeley, California), 3 μl of water, 40 pmole
of the CTX-Mu forward and 40 pmole of the reverse primers, and 2 ul
of sample total or plasmid DNA. A plastic cover was placed over the
top of the 96-well plate, and the plate was placed into the Lightcycler
480 thermocycler (Roche Diagnostics, Indianapolis, IN). Real-time PCR
conditions were as follows: initial denaturation at 95°C for 5 min; 30 cycles of 95°C for 25s, 60°C for 30s; and 72°C for 30s with continuous detection followed by melt-curve analysis with a gradual temperature
increase from 68°C to 95°C at 0.2°C/s. Ampliﬁcation products with
melt-curves that had peaks within +/- 1.0 °C of the peak from a CTXM-15 speciﬁc positive control (Hanson et al., 2008) were considered

Genomic DNA was prepared from the index S. Isangi isolates from
each of the 19 patients as well as the two additional isolates from “Patient P” in agarose plugs, digested with XbaI (New England BioLabs, Beverly, MA), and run on a CHEF-DR III (Bio-Rad Laboratories, Hercules, CA)
as previously described (Donabedian et al., 1995). BioNumerics
software (Applied Maths, Kortrijk, Belgium) was used to calculate the
percent similarity (Dice coefﬁcient) of XbaI pulsed-ﬁeld gel electrophoresis (PFGE) banding patterns according to Zou et al (Zou et al.,
2010). Isolates were considered related if their PFGE banding patterns
were ≥95.0% similar.
3. Results
3.1. Isolates and antimicrobial susceptibilities
A total of 45 Salmonella isolates from 19 patients and one HCW were
isolated from stool (35), blood (4) urine (3), respiratory (2) and wound
(1) cultures. Serotyping performed at MDHHS indicated that these isolates shared the same antigenic formula 6,7:d:1,5, consistent with the
rare C1-subgroup, serotype Salmonella Isangi. The most common phenotype among the isolates was resistance to ampicillin (amp), ampicillin/sulbactam (amp-sul), cefazolin (cef), ceftriaxone (ctx), and cefepime
(fep) and susceptible to ertapenem (ert), meropenem (mer),
trimethoprim-sulfa/sulfamethoxazole (TMX) and ciproﬂoxacin (cip)
(Table 1). Further, minimum inhibitory concentrations (MIC) to
piperacillin-tazobactam (pip-tazo) were the most variable among the
isolates and ranged from 8 to 128 ug/ml. Two isolates were resistant
to TMX and one to ertapenem. Three isolates had a phenotype that
was susceptible to all drugs listed above. Three isolates from a single patient, “Patient P”, had differing resistance patterns: R1 was consistent
with the more common resistant phenotype, while the other two, S1
and S2, were consistent with the susceptible phenotype.
3.2. Real-time PCR Analysis
Of the 45 isolates tested, all but three were positive for CTX-M-15
using the universal CTX-M primer set from total and plasmid-only extracted DNA (data not shown). Included in these were three isolates
from a single patient (Patient P); isolate R1 was positive for CTX-M-15
from both extractions, while the other two, S1 and S2, were negative
from both extractions (Fig. 1). A pan-susceptible, CTX-M-15 negative,
S. Isangi isolate from a different patient was used for negative control
(Fig. 1).

Table 1
MIC50's in ug/ml for the antimicrobials tested based on the presence of CTX-M15 ESBL*.

MIC50's in ug/ml for the antimicrobials tested based on the presence of CTX–M15 ESBL*

CTX–M15 Positive (n=19)
"Resistant Phenotype"
CTX–M15 Negative (n=3)
"Susceptible Phenotype"

Amp

Amp
Sul

Pip
Tazo**

Cef

Ctx

Fep

Azt

Ert

Mer

TMX***

Cip

32

32

8

≥64

≥64

≥64

≥64

≤0.5

≤0.25

≤20

1

8

4

8

1

1

1

1

≤0.5

≤0.25

≤20

1

* Red = resistant, Green = susceptible.
** The patterns above were consistent for all antimicrobials except Pip/Tazo which had the greatest variability with
a MIC range of 8 to 128 ug/ml.
*** Two isolates had TMX MIC's of 160 ug/ml
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R1

S1 and S2

Pos

Neg

Fig. 1. Real-time PCR melt-curve analysis of the three isolates of S. Isangi from Patient P showing the presence of CTX-M-15 ESBL in isolate R1 and lack of the same in isolates S1 and S2.
Positive and negative controls are indicated. All remaining resistant isolates in the study had melt-curves consistent with R1. Melting curve peaks between R1 and Pos control is 0.52 °C.

3.3. Pulse Field Gel Electrophoresis (Fig. 2)
A total of 8 unique strains (1a – 1h) of no more than 3 band differences among them were identiﬁed among all 22 isolates with an overall
similarity of ~86%. There was one large distinct cluster (1a) comprised of
18 of the isolates with ~96% similarity. The remaining 4 isolates were no
less the 85% similar to all other isolates. The pan-susceptible S1 and S2
isolates from Patient P were 100% identical and were included in
strain-type 1g, while the resistant R1 isolate from Patient P was in its
own strain-type 1f; however, similarity among the 3 isolates was 86%.
4. Discussion
Over the course of approximately seven weeks, a nosocomial outbreak of S. Isangi was identiﬁed among 19 surgical patients and one
HCW. Although this is the ﬁrst reported S. Isangi outbreak in the US, S.
Isangi has become increasing common in southern Africa and was reported only second to Salmonella Typhimurium in South Africa in
2002, accounting for 20% of the isolates in a nationwide surveillance
program (Usha et al., 2008; Kruger et al., 2004). Most NTS infections
are foodborne, but intra-familial, day-care, and nosocomial outbreaks
have been reported (Wadula et al., 2006; Woerther et al., 2013; Lee
and Greig, 2013). However, the only reported nosocomial outbreak of
S. Isangi occurred among 41 pediatric patients at a tertiary hospital in
South Africa. All isolates were ESBL-producers (Wadula et al., 2006).
Historically, ESBL-producing Enterobacteriaceae such as Klebsiella
spp. emerged shortly after the availability of broad-spectrum cephalosporins in the early 1980s (Woerther et al., 2013). After being ﬁrst described in Tunisia in 1988, ESBLs in Salmonella spp. have since
increased in prevalence worldwide (Usha et al., 2008), particularly in
developing countries where extended-spectrum cephalosporins are
the mainstay of treatment for invasive NTS, including S. Isangi. (Usha
et al., 2008; Wadula et al., 2006; Kruger et al., 2004). A national surveillance program in South Africa reported the rate of ESBL in NTS to be
17.7% in 2007 with 33.8% of isolates being resistant to ﬁve or more antimicrobial agents (Usha et al., 2008). Multi-drug resistance in Salmonella
is primarily mediated by resistance genes associated with mobile genetic elements such as plasmids, transposons, and integrons encoding ESBL
enzymes, including TEM, SHV, OXA, and CTX-M, and Amp-C beta
lactamases (Usha et al., 2008; Kruger et al., 2004; Woerther et al.,

2013; Krauland et al., 2010). Additionally, studies have shown that Salmonella spp. can harbor multiple ESBL enzyme-types simultaneously
(Usha et al., 2008).
SHV and TEM were the predominant ESBL enzymes produced by
Enterobactereciae and a major cause of nosocomial infections since
1980s. However, community-onset E. coli associated with CTX-M enzymes was identiﬁed in the late 1990s, and these enzymes, particularly
CTX-M-15, have become the dominant ESBL type due to their highly
mobile genetic elements between strains resulting in outbreaks in the
last 10 years (Dropa et al., 2015; Woerther et al., 2013). Intercontinental
travel has allowed the spread in communities and led to a global pandemic (Woerther et al., 2013). Interestingly, the index patient was
born in the Middle-East but was a resident of Venezuela and had traveled to Mexico, Colombia, and Spain. These enzymes are encoded by
transferrable plasmids, have a high afﬁnity for cefotaxime, and are divided into ﬁve clusters based on amino acid sequences: CTX-M-1,
CTX-M-2, CTX-M8, CTX-9, CTX-M-25 (Dropa et al., 2015; Woerther
et al., 2013; Lascols et al., 2012; Pitout and Laupland, 2008). The CTXM-1 group, which includes CTX-M-15, is the most prevalent allele
worldwide. Moreover, S. Isangi has acquired various CTX-M enzymes,
including CTX-M-1, CTX-M-3, CTX-M-15, CTX-M-22, and CTX-M37(Usha et al., 2008; Wadula et al., 2006; Kruger et al., 2004; Roschanski
et al., 2014).
In our study, a total of 45 S. Isangi isolates were identiﬁed. All S.
Isangi isolates, with the exception of three, were ESBL-producers. The
phenotypically resistant S. Isangi isolates were resistant to the penicillins, monobactams, and cephalosporins with variable susceptibility to
piperacillin/tazobactam (Table 1). All isolates but one were susceptible
to carbapenems. With the exception of two isolates, all were susceptible
to trimethoprim/sulfamethoxazole. These patients were solid organ
transplant recipients and were receiving trimethoprim/sulfamethoxazole prophylaxis. However, three isolates, two of which were from the
same patient, were phenotypically susceptible to all the listed drugs
(Table 1). Interestingly, one patient had three isolates with different resistance patterns: the index isolate, R1, was consistent with the resistant
phenotype, while the two subsequent isolates, S1 and S2, were consistent with the susceptible phenotype (Fig. 1, Table 1). ESBL-production
may have been selected as β-lactams are used for perioperative antibiotic prophylaxis at our institution. Additionally, RT-PCR using universal
CTX-M primer set from total and plasmid-only extracted DNA
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PFGE
Strain

100

98

96

94

92

90

88

95%
86

389

S1
1g
S2
1b

1a

1d
1g
1c
1h
R1

1f

Fig. 2. PFGE dendogram of the ﬁrst isolated S. Isangi from each patient (n=22) as well as two additional isolates from Patient P (R1, S1, S2). A total of 8 unique strains (1a – 1h) were
identiﬁed among all 22 isolates with an overall similarity of ~86%. There was one large distinct cluster (Cl-1) comprised of 18 of the isolates with ~96% similarity with the remaining 4
isolates no less the 85% similar to the remaining isolates. * = Index patient (resistant S. Isangi, ** Patient (susceptible S. Isangi).

demonstrated the presence of a CTX-M-15 ESBL in all phenotypically resistant S. Isangi isolates, whereas the three phenotypically susceptible
isolates lacked this enzyme. The change in phenotypic susceptibilities
and CTX-M possession might be explained by the mobile genetic elements possessed by this organism as discussed previously. Horizontal
transfer of genetic elements or clonal expansion of resistance strains
leads to dissemination of drug resistance in Salmonella. Studies have
shown that the introduction of ﬁt Salmonella clones can either expand
or displace existing populations, enabling the spread of resistance
through clonal expansion (Krauland et al., 2010). Moreover, PFGE indicated that the S. Isangi isolates were highly related with an overall similarity of ~86% on PFGE analysis, suggesting clonal dissemination
(Fig. 2).

5. Conclusion
In this study, we detected an ESBL S. Isangi possessing CTX-M-15 enzyme during a seven-week outbreak period at our institution. It is believed that this strain is unique in the US as no matches were found in
the National PulseNet database over the past two years (Personal communication, Dr Rudrik MDHSS). However, it is likely that this strain harbors additional ESBL enzymes as shown in previous studies (Usha et al.,
2008), which will need to be explored. This study illustrates that multidrug resistant Salmonella, which is becoming increasingly common
worldwide, has the potential to develop increasing antimicrobial resistance and disseminate quickly among patients with infection control
and treatment implications.
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